Ha Jihwan
Major of Big Data Convergence, Division of Data Information Science, Pukyoung National University, Busan 48513, Korea.
J Pers Med. 2022 May 27;12(6):885. doi: 10.3390/jpm12060885.
MicroRNAs (miRNAs) have drawn enormous attention owing to their significant roles in various biological processes, as well as in the pathogenesis of human diseases. Therefore, predicting miRNA-disease associations is a pivotal task for the early diagnosis and better understanding of disease pathogenesis. To date, numerous computational frameworks have been proposed to identify potential miRNA-disease associations without escalating the costs and time required for clinical experiments. In this regard, I propose a novel computational framework (MDMF) for identifying potential miRNA-disease associations using matrix factorization with a disease similarity constraint. To evaluate the performance of MDMF, I calculated the area under the ROC curve (AUCs) in the framework of global and local leave-one-out cross-validation (LOOCV). In conclusion, MDMF achieved reliable AUC values of 0.9147 and 0.8905 for global and local LOOCV, respectively, which was a significant improvement upon the previous methods. Additionally, case studies were conducted on two major human cancers (breast cancer and lung cancer) to validate the effectiveness of MDMF. Comprehensive experimental results demonstrate that MDMF not only discovers miRNA-disease associations efficiently but also deciphers the underlying roles of miRNAs in the pathogenesis of diseases at a system level.
微小RNA(miRNA)因其在各种生物过程以及人类疾病发病机制中的重要作用而备受关注。因此,预测miRNA与疾病的关联是疾病早期诊断和深入了解疾病发病机制的关键任务。迄今为止,已经提出了许多计算框架来识别潜在的miRNA与疾病的关联,而无需增加临床实验所需的成本和时间。在这方面,我提出了一种新颖的计算框架(MDMF),用于使用具有疾病相似性约束的矩阵分解来识别潜在的miRNA与疾病的关联。为了评估MDMF的性能,我在全局和局部留一法交叉验证(LOOCV)框架下计算了ROC曲线下的面积(AUC)。总之,MDMF在全局和局部LOOCV中分别获得了可靠的AUC值0.9147和0.8905,这比以前的方法有了显著改进。此外,对两种主要的人类癌症(乳腺癌和肺癌)进行了案例研究,以验证MDMF的有效性。综合实验结果表明,MDMF不仅能够高效地发现miRNA与疾病的关联,还能在系统水平上解读miRNA在疾病发病机制中的潜在作用。